Ophiasis alopecia areata treated with microneedling.
Study Design
- 研究タイプ
- case report
- サンプルサイズ
- 1
- 期間
- 24 weeks
- 介入
- Ophiasis alopecia areata treated with microneedling. 4 microneedling sessions with triamcinolone over 6 months; clobetasol 0.05% solution
- 比較対照
- Placebo
- 効果の方向
- Positive
- バイアスリスク
- High
Abstract
Alopecia areata (AA) is a T cell-mediated autoimmune disease resulting in the destruction of hair follicles. Ophiasis refers to a subtype of AA that presents as a symmetric, band-like hair loss pattern of the occipital, temporal, and parietal regions of the scalp. We present a case of a 58-year-old white man with AA, ophiasis pattern, who was treated with clobetasol 0.05% solution and four treatments of microneedling with triamcinolone over 6 months. He underwent gradual improvement, most notably on his left occipital scalp where his hair loss was most prominent, with near complete hair regrowth on his left occipital scalp. Microneedling with triamcinolone can be considered as a promising treatment in cases of ophiasis AA.
Used In Evidence Reviews
Similar Papers
International journal of trichology · 2013
A randomized evaluator blinded study of effect of microneedling in androgenetic alopecia: a pilot study.
Journal of plastic, reconstructive & aesthetic surgery : JPRAS · 2018
Microneedling: Where do we stand now? A systematic review of the literature.
Dermatologic therapy · 2019
Physiopathology and current treatments of androgenetic alopecia: Going beyond androgens and anti-androgens.
Journal of the European Academy of Dermatology and Venereology : JEADV · 2018
Microneedling for the treatment of hair loss?
Indian journal of dermatology · 2015
Response to Microneedling Treatment in Men with Androgenetic Alopecia Who Failed to Respond to Conventional Therapy.
Journal of cutaneous and aesthetic surgery · 2014